Skip to main content
PLOS Neglected Tropical Diseases logoLink to PLOS Neglected Tropical Diseases
. 2023 Oct 26;17(10):e0011716. doi: 10.1371/journal.pntd.0011716

The epidemiology of fecal carriage of nontyphoidal Salmonella among healthy children and adults in three sites in Kenya

Esther M Muthumbi 1,2,*, Alfred Mwanzu 1, Cecilia Mbae 3, Godfrey Bigogo 4, Angela Karani 1, Salim Mwarumba 1, Jennifer R Verani 5, Samuel Kariuki 3, J Anthony G Scott 1,2
Editor: Kamala Thriemer6
PMCID: PMC10629669  PMID: 37883602

Abstract

Background

Despite the importance of non-Typhoidal Salmonella (NTS) disease in Africa, epidemiologic data on carriage and transmission are few. These data are important to understand the transmission of NTS in Africa and to design control strategies.

Method

To estimate the prevalence of stool carriage of NTS in Kenya, we conducted a cross-sectional study in Kilifi, Nairobi, and Siaya, sites with a low, moderate and high incidence of invasive NTS disease, respectively. At each site, we randomly selected 100 participants in each age-group of 0–11 months, 12–59 months, 5–14 years, 15–54 years and ≥55 years. We collected stool, venous blood (for hemoglobin and malaria rapid tests), anthropometric measurements, and administered a questionnaire on Water Access Sanitation and Hygiene (WASH) practices. Stool samples were cultured on selective agar for Salmonella; suspect isolates underwent serotyping and antimicrobial susceptibility testing.

Result

Overall, 53 (3.5%) isolates of NTS were cultured from 1497 samples. Age-adjusted prevalence was 13.1% (95%CI 8.8–17.4) in Kilifi, 0.4% (95%CI 0–1.3) in Nairobi, and 0.9% (95%CI 0–2.0) in Siaya. Prevalence was highest among those aged 15–54 years (6.2%). Of 53 isolates; 5 were S. Enteritidis, 1 was S. Typhimurium. No S. Typhi was isolated. None of the risk factors were associated with carriage of NTS. All isolates were susceptible to all antibiotics tested, including ampicillin, chloramphenicol, ciprofloxacin and co-trimoxazole.

Conclusion

Prevalence of fecal carriage was high in Kilifi, an area of low incidence of invasive NTS disease and was low in areas of higher incidence in Nairobi and Siaya. The age-prevalence, risk factors, geographical and serotype distribution of NTS in carriage differs from invasive disease.

Author summary

Infections with non-typhoidal Salmonella (NTS) bacteria can present as asymptomatic carriage, diarrhoea or invasive disease. Worldwide, invasive NTS disease (iNTS) is more common in Africa, especially among children, and is commonly caused by two serotypes: S. Typhimurium and S. Enteritidis. Recent studies suggest that transmission of these serotypes causing iNTS is human to human. Consequently, identifying the age-group and risk factors associated with asymptomatic carriage of NTS would help in controlling its transmission. We randomly sampled healthy children and adults across 3 sites in Kenya with carrying iNTS incidence. We found that carriage is highest among older children and adults, who can be targeted to reduce its transmission. We also found that carriage was highest in Kilifi, the area of low iNTS incidence, it was not associated with known risk factors for iNTS, and majority of the serotypes were neither S. Typhimurium nor S. Enteritidis. These differences between NTS carriage and invasive disease need further investigations to understand the linkages and inform control.

Introduction

Transmission of non-typhoidal Salmonella (NTS) has been associated with contamination of food and with direct contact with chickens or reptiles [13]. These findings come from high-income countries where NTS disease is characterized by a self-limiting gastroenteritis, with an incidence of 634 per 100,000 cases per year in Europe and North America, and with a case fatality ratio (CFR) of 0.2% [4]. By contrast, NTS disease in Africa is more frequently invasive, causes little or no diarrhea, and has a higher CFR [5]. In 2017, the incidence of invasive NTS (iNTS) disease was 34.5 cases per 100,000 person-years, and CFR of 16% across sub-Saharan Africa [6].

The genotypes most commonly causing iNTS disease in Africa, Salmonella Typhimurium and Enteritidis, have no known animal reservoir [7]. Genetic analysis in Kenya has previously shown that Salmonella Typhimurium isolates obtained from index cases of NTS bacteremia in children and their human contacts are identical but are distinct from those found in their animal contacts [8]. Similar observations have been made in The Gambia [9] and Burkina Faso [10]. It has been postulated that transmission of iNTS disease in Africa is principally human to human [7]. This theory has been strengthened by the discovery of a novel sequence type of Salmonella Typhimurium, ST313, and a novel clade of Salmonella Enteritidis, ‘the African clade’, which are leading causes of iNTS in Africa and whose genomes have undergone changes in a pattern that is associated with host restriction, similar to Salmonella Typhi [11,12]. If the transmission is human-to-human, then the subgroup of the population that are carriers acts as an important reservoir for the organism and may be the main source of infection.

Fecal shedding, especially in settings with suboptimal hygiene and sanitation, could lead to high transmission rates driving a high risk of invasive disease. However, the epidemiology of carriage of NTS and its association with iNTS in Africa, are not well understood. We aimed to explore the epidemiology of carriage in Kenya by studying healthy individuals from three sites with different incidence of iNTS disease.

Method

Ethics statement

Written informed consent was obtained from all adult participants and from the guardians of children aged <18 years old. Assent was obtained from all participants aged 13–17 years old. The study was approved by the Kenya Medical Research Institute (KEMRI) Scientific and Ethics Research Unit (SERU No. 3221). This activity was reviewed by CDC and was conducted in a manner consistent with applicable federal law and CDC policy [Project ID: 0900f3eb81e92cdd].

Study sites

The study sites were: Junju location in Kilifi County, Mukuru in Nairobi County, and Asembo location in Siaya County. Junju location is a rural setting with a population of approximately 34,000 people over 115 km2. [13] Mukuru is a densely populated urban slum area, with approximately 250,000 people in an area of 3 km2, Asembo is a sparsely populated rural location, with a population of approximately 25,000 people over 100 km2 in a defined surveillance catchment area [13,14]. The distribution of risk factors for iNTS disease differs by site. Malaria prevalence was estimated as 8%, 0.2% and 26% in Kilifi, Nairobi and Siaya [15], respectively, while HIV prevalence was estimated as 3%, 5% and 14%, respectively [16]. The incidence of iNTS disease in children under 5 years is estimated as 36–88 per 100,000 person-years in Kilifi and 501–3914 per 100,000 person-years in Siaya [1719]. The incidence of iNTS in Mukuru slums has not been estimated previously, but can be inferred from that of neighboring Kibera slums as 255–998 per 100,000 person-years [19].

Sampling framework

Sampling was done in October-November 2016 in Kilifi, May-September 2017 in Nairobi and June-September 2017 in Siaya. In Kilifi and Siaya, we used existing population registers as our sampling frame; these were available from the Kilifi Health and Demographic Surveillance System (KHDSS) [20] and from the Population-Based Infectious Disease Surveillance (PBIDS) [14] platform, which is nested within the KEMRI/CDC demographic surveillance system [21]. We undertook age-stratified, simple random sampling of the entire population register of the Junju and Asembo locations. To create a sampling frame in Mukuru, Nairobi, we used Google Earth, a GIS software (QGIS), and a high-resolution satellite image of the area. We generated random points in the study area and excluded points on schools, churches, and community halls when the points were identified in maps from Open Street Maps (http://openstreetmaps.org). At high resolution, the area had already been mapped into residential blocks by an ongoing Salmonella project [22]. We used random residential-block sampling followed by systematic age-stratified sampling. At each site we sampled 100 participants in each of five age strata: 1–11 months, 12–59 months, 5–14 years, 15–54 years, 55 years and above. Random lists of potential participants were created in each site in excess of the sample size targeted and any selected individuals who were absent or unwilling to participate (or any households in Nairobi that did not contain an age-appropriate participant) were replaced by selecting the next individual on the random list.

Patient/Public Participation

Community Engagement with the public was performed before study recruitment. We held community barazas organised by the location chiefs, meetings with community representatives, and the Department of Health in Nairobi County and Kilifi County where we discussed the study. We highlighted the background of the study, study design, recruitment procedures, participants involvement, risks and benefits of the study. Peer reviewed research findings will be disseminated to participants and the participating communities upon completion of the study in dissemination meetings following the same channels.

Interview and specimen collection

Following informed consent, study participants were given the choice to be interviewed at their home or in a local health clinic. A questionnaire was administered, and the participant was asked to provide a stool sample. The questionnaire inquired about demographics, sanitation practices, food and water consumption, ownership and contact with animals, clinical status in the preceding 2 weeks, and household crowding. For those interviewed at the clinic, a blood sample was taken for HRP2-based P. falciparum malaria rapid test and hemoglobin measurement (Mission strips). Anthropometric measures (height/length, weight and Mid-Upper Arm Circumference [MUAC] for children under 5 years) were also taken.

No samples were collected between 1st and 23rd August 2017 due to the Kenyan national elections. Those unable to produce a stool sample immediately were given a sterile pot for stool sampling at home the following morning and the sample was collected by study fieldworkers before noon. Both at home by the fieldworkers and at the clinic, an aliquot of the stool sample was inserted in Cary-Blair transport media for culture and preserved at 2–4°C in a cooler. Within 8 hours of collection, the stool samples were transported to a microbiology laboratory for processing.

Samples from Kilifi, Nairobi, and Siaya were processed in laboratories at KEMRI-Wellcome Trust Programme in Kilifi, KEMRI-Center for Microbiological Research in Nairobi and KEMRI Centre for Global Health Research- laboratories in Kisumu, respectively. The data collection tools and laboratory methods were standardized across all sites.

Laboratory testing

In the laboratory, culture samples were incubated overnight in Selenite F broth (Oxoid microbiological products) for enrichment and sub-cultured onto selective media (Xylose Lysine Deoxycholate agar (XLD), Salmonella/Shigella agar (SS) agar and Brilliant Green media) to select for Salmonella enterica species. Species were confirmed using biochemical testing (API 20E). Salmonella Typhimurium and Salmonella Enteritidis were determined using the Kauffman-White scheme and commercial antisera. Antimicrobial susceptibility testing was performed and interpreted using Clinical Laboratory Standards Institute (CLSI) guidelines, for the following antimicrobials: ampicillin 10μg, amoxicillin/clavulanate 20/10 μg, cotrimoxazole 1.25/23.75μg, cefotaxime 10μg, chloramphenicol 10μg, ciprofloxacin 5μg, ceftazidime 30μg, ceftriaxone 30μg, imipenem 10μg, cefoxitin 30μg and amikacin 30μg [23].

Data analysis

The prevalence of carriage in stool in each age stratum was estimated as the proportion of sampled individuals who had a positive stool culture and exact 95% confidence intervals were calculated. To account for the sampling scheme, total population prevalence for each site was age standardized using the age structure of the local population as population weights.

We defined underweight (weight-for-age Z score [WAZ] <-2); wasting (weight-for-height Z score [WHZ] <-2); and stunting (height-for-age Z score [HAZ] <-2) for children under 5 years using WHO Child Growth Standards [24]. Anemia was defined as hemoglobin <10g/dl, and recent malaria infection was defined as malaria HRP-2 rapid test positive. Risk factor analyses were conducted using Poisson regression with robust standard errors to estimate prevalence ratios. The outcome variable was presence of NTS in the stool samples. Variables associated with the outcome variable at a p<0.05 significance level were selected for inclusion in a multivariable regression model, including age, sex and site as a priori explanatory variables. Statistical analyses were performed using STATA v.13.

Results

In Kilifi, 775 residents were selected for inclusion in the study, 506 were enrolled and 494 (response rate, 63.7%) were sampled. In Nairobi, 750 random points were generated by the software, 510 participants were enrolled and 504 (67.2%) were sampled. In Siaya, 607 residents were selected for the study, 506 were enrolled and 499 (82.2%) were sampled. In total, we sampled 1,497 participants; 703 (47%) were male (Table 1).

Table 1. Participant characteristics at enrollment, by site, Kenya (2016–17).

Kilifi Nairobi Siaya
n/N % n/N % n/N %
Participant characteristics
 Sex Male 220/494 44.5 266/504 52.8 217/499 43.5
 Pregnant, in females >18y 2/115 1.7 3/73 4.1 2/126 1.6
 Recent malaria Positive 23/307 7.5 11/443 2.5 139/489 28.4
 Wasting, in < 5y WHZ <-2 20/181 11.1 15/214 7.5 6/200 3
 Stunting, in < 5y HAZ <-2 50/198 25.3 43/214 20.1 42/200 21
 Underweight, in < 5y WAZ <-2 30/181 16.7 16/214 7.5 16/200 8
 Acute Malnutrition, in < 5y MUAC <12.5cm 34/197 17.3 54/212 25.5 8/200 4
 Fever in last 2 weeks Yes 61/458 13.3 47/486 9.7 152/499 30.5
 Diarrhea in last 2 weeks Yes 25/458 5.5 61/486 12.6 35/499 7
 Admitted in last 2 weeks Yes 7/458 1.5 11/486 2.3 7/499 1.4
Household characteristics
 Household member fever in last 2 weeks Yes 44/458 9.6 26/486 5.4 156/499 31.3
 Household member diarrhea in last 2 weeks Yes 17/458 3.7 40/486 8.2 39/499 7.8
WASH Practices
 Source of drinking water Piped water 80/458 17.5 4/486 0.8 18/499 3.6
Public tap 236/458 51.5 482/486 99.2 214/499 42.8
River/Lakes 1/458 0.2 0/486 0 77/499 15.4
Well/Dams/Borehole 141/458 30.8 0/486 0 190/499 38.1
 Uses soap for hand washing Yes 351/458 76.6 471/486 96.9 463/499 92.8
 Uses shared basin for washing hands Yes 192/458 41.9 131/486 26.9 58/499 11.6
 Toilet Type Modern with/without flush 50/458 10.9 63/486 12.9 2/499 0.4
Pit latrine 394/458 86.1 392/486 80.7 479/499 95.9
None/Open defecation 10/458 2.2 1/486 0.2 10/499 2
Other 4/458 0.1 30/486 6.2 8/499 1.6
 Animal Ownership Cattle 61/458 13.3 2/486 0.4 305/499 61.1
Sheep 4/458 0.9 1/486 0.2 142/499 28.5
Goats 129/458 28.2 8/486 1.7 194/499 38.9
Pigs 1/458 0.2 1/486 0.2 3/499 0.6
Chickens 256/458 55.9 57/486 11.7 452/499 90.6

Out of the 1,497 stool samples collected, 53 NTS isolates were recovered (crude prevalence 3.5%, 95% CI 2.6, 4.6%). Crude carriage prevalence was 9.3% (46/494) in Kilifi, 0.2% (1/504) in Nairobi and 1.2% (6/499) in Siaya. In Kilifi, the prevalence varied significantly by age (p = 0.035) and was low in infancy, highest in the 15–54 year age stratum at 17.4%, and lower in older age groups. The prevalence did not vary significantly by sex (p = 0.123, Table 2). When standardized using age-specific population weights at each site, the total population prevalence was 13.1%, 0.4%, 0.9% in Kilifi, Nairobi and Siaya, respectively.

Table 2. Age and sex-related prevalence of stool carriage of NTS in Kenya (2016–17).

Kilifi Nairobi Siaya
n/N* % 95% CI n/N* % 95% CI n/N* % 95% CI
Female
 0–11 m 3 / 55 5.5 1.1, 15.1 0 / 44 0 1 / 48 2.1 0,11.1
 12–59 m 4 / 51 7.8 2.2, 18.8 0 / 50 0 0 / 62 0
 5–14 y 7 / 45 15.6 6.5, 29.5 0 / 72 0 0 / 51 0
 15–54 y 10 / 53 18.9 9.4, 31.9 1 / 57 1.8 0, 9.4 1 / 51 1.9 0,10.4
 55+ y 6 / 70 8.6 3.2, 17.7 0 / 15 0 1 / 70 1.4 0, 7.7
 Total 30 / 274 10.9 7.5, 15.3 1 / 238 0.4 0, 2.3 3 / 282 1.1 0.2, 3.1
Male
 0–11 m 5 / 71 7.0 2.3, 15.7 0 / 64 0 1 / 49 2 0, 10.9
 12–59 m 2 / 43 4.7 0.6, 15.8 0 / 57 0 1 / 41 2.4 0, 12.9
 5–14 y 3 / 40 7.5 1.6, 20.4 0 / 79 0 0 / 57 0
 15–54 y 5 / 33 15.2 5.1, 31.9 0 / 49 0 0 / 33 0
 55+ y 1 / 33 3.0 0, 15.8 0 / 17 0 1 / 37 2.7 0, 14.2
 Total 16 / 220 7.3 4.2, 11.5 0 / 266 0 3 / 217 1.4 0.3, 4.0
All
 0–11 m 8 / 126 6.4 2.8, 12.1 0 / 108 0 2 / 97 2.1 0.3, 7.3
 12–59 m 6 / 94 6.4 2.4, 13.4 0 / 107 0 1 / 103 0.9 0, 5.3
 5–14 y 10 / 85 11.8 5.8, 20.6 0 / 151 0 0 / 108 0
 15–54 y 15 / 86 17.4 10.1, 27.1 1 / 106 0.9 0,5.1 1 / 84 1.2 0, 6.5
 55+ y 7 / 103 6.8 2.8, 13.5 0 / 32 0 2 / 107 1.9 0.2, 6.6
 Total 46 / 494 9.3 6.9, 12.2 1 / 504 0.2 0,1.1 6 / 499 1.2 0.4, 2.6
Age-standardized prevalence (local population) 13.1 8.8, 17.4 0.9 0, 2.0 0.4 0, 1.3

*n/N number of positive cultures divided by the number of stool samples cultured

Serotype distribution and antimicrobial susceptibility patterns

Out of the 53 NTS isolates, 5 were S. Enteritidis, one was S. Typhimurium and the remaining 47 could not be typed fully by the anti-sera available (Table 3). Of the S. Enteritidis serotypes, 3 were in infants, 1 in a child 12–59 months, and 1 in an adult 15–54 years, while the single isolate of S. Typhimurium was in an adult >55 years. S. Typhi was not isolated in any of the sites. The distribution of S. Enteritidis and S. Typhimurium, did not vary by site, however, the prevalence of the other serotypes was higher in Kilifi (43/494, 8.7%), than in Nairobi (1/504, 0.2%) and Siaya (3/499, 0.6%), p<0.001. All the 53 NTS isolates were susceptible to the antibiotics tested in the panel.

Table 3. Serotype distribution of NTS isolates by site, Kenya, (2016–17).

Kilifi Nairobi Siaya Total
S. Enteritidis 3 0 2 5
S. Typhimurium 0 0 1 1
Other Group D 3 0 0 3
Other Group B 11 0 1 12
Other serotypes 29 1 2 32
Total 46 1 6 53

Risk factors associated with fecal carriage of NTS

The distribution of risk factors among the participants varied by site (Table 1). The prevalence of anemia (hemoglobin <10g/dl) was 20% (58/290) in Kilifi, 7% (31/433) in Nairobi and 9% (20/277) in Siaya. Prevalence of asymptomatic P. falciparum infection was 8% (23/307) in Kilifi, 3% (11/443) in Nairobi and 28% (139/489) in Siaya. The prevalence of acute malnutrition (MUAC <12.5cm) among children aged less than 5 years was 16% (34/209) in Kilifi, 23% (54/233) in Nairobi and 4% (8/200) in Siaya. The distribution of animals kept also differed by site: there were more animals kept in Siaya than in any other site, but chicken farming was practiced across all sites (Table 1). As expected, more animals were kept among participants in the rural areas (Kilifi and Siaya) than in the urban slum area of Mukuru.

We did not include data from Nairobi in this analysis because there was only one positive culture among the 504 samples tested. In the univariate analysis of risk factors for prevalent NTS carriage, anemia (hemoglobin <10g/dl), recent malaria and malnutrition were not associated with NTS carriage (S1 Table). The risk of carriage was higher among participants who used a shared basin for washing hands than among those who washed separately (Prevalence Ratio 2.7, 95% CI 1.6, 4.7), but was not associated with any of the other WASH-related exposures assessed. Ownership of cattle and sheep was associated with a reduced risk of carriage of NTS (S1 Table). In addition, contact with cattle, goats, sheep or chickens was also associated with a reduced risk of carriage of NTS (S1 Table).

In the multivariable model including age and site as covariates, none of the risk factors that were significant on univariate analysis were associated with fecal carriage of NTS.

Discussion

In this study, the prevalence of NTS carriage varied very markedly by site from 0.4% and 0.9% in Nairobi and Siaya to 13.1% in Kilifi. Overall, serotypes commonly associated with invasive disease accounted for only 6 of 53 carriage isolates and the high prevalence in Kilifi may have been related to the presence of serotypes other than S. Typhimurium/S. Enteritidis. Carriage prevalence in Kilifi was highest in young/middle aged adults and was not associated with sex. We observed no in vitro resistance to commonly used antimicrobials tested against our NTS isolates.

The observed carriage prevalence in Kilifi (13.1% all ages and 6.4% in <5y) is higher than that reported in previous population-based studies on fecal carriage of NTS among children and adults across several sites in Africa. For example, carriage prevalence across all ages was 1.0% in Dakar, Senegal, 2.4% in Bissau, Guinea-Bissau and 3.4% in Kifua, Democratic Republic of Congo (DRC) [25,26] while among children aged <5 years in the Global Enteric Multicenter Study (GEMS), the observed prevalence was 1.3% in Basse, The Gambia, 0% in Bamako, Mali and 0.1% in Manhica, Mozambique. However, the observed prevalence (1.5%, 95%CI 0.3–4.3) in Siaya among children aged <5 years in our study is comparable to that observed from GEMS study at the same site (3.2%, 2.5–4.1) [27].

The majority of the invasive serotypes isolated across Africa are S. Typhimurium or S. Enteritidis [28] though these serotypes represented only 11% (6/53) of the carried isolates in our study. In Senegal, Guinea-Bissau, DRC, The Gambia, Mozambique and Siaya (GEMS), these pathogenic serotypes were only detected in The Gambia (9/38, 24%) and Siaya (25/59, 41%) of all carriage serotypes isolated. The invasiveness of a given serotype can be expressed as the proportion of the serotype among invasive isolates divided by the proportion among carriage isolates [29]. In a previous study in Kilifi, these two pathogenic serotypes were responsible for 89% (312/351) of iNTS disease [17], yet account for only 6.5% (3/46) of carriage in this study; and in Siaya they were responsible for 98% (59/60) of iNTS disease in a previous study [30] and 50% (3/6) carriage in this study. Although estimation of relative invasive index is beyond the scope of this analysis (which included only carriage isolates), our findings suggest that these serotypes are more common among invasive isolates than among carriage isolates, and that the prevalence may vary across different settings. The outcome of an infection with Salmonella serotype depends on host susceptibility [7,31], infective dose [32] and pathogen virulence [3335]. Furthermore, within-serotype differences in invasiveness have been demonstrated among different sequence types of S. Typhimurium [36], suggesting that the broad serotype classification may not capture all the attributes of invasiveness; classifications based on genotype may be more useful [37].

The antibiograms of the 53 isolates showed a full susceptibility profile, which is in marked contrast to the multi-drug resistant profiles seen in other NTS isolates [7], especially among invasive S. Typhimurium serotypes suggesting that resistance could be linked to virulence. In other studies, the same resistance profiles have been observed in asymptomatic and symptomatic isolates [27,3841], suggesting that invasive disease may arise out of the pool of carried strains. However, the transmission of isolates causing asymptomatic carriage and of isolates causing iNTS may also differ and the relationship between carriage of antimicrobial resistant strains and the occurrence of drug-resistant invasive disease is not clearly understood.

Within country differences in the frequency of iNTS disease have been documented, and have mostly been attributed to differences in urbanization, agricultural practices and the presence of risk factors for invasive diseases such as malaria and HIV [19,42]. In this study, the prevalence of recent malaria was higher in Siaya (28%) than in Kilifi (7%) or Nairobi (2%). There were geographical differences in the occurrence of other host risk factors such as undernutrition in children but none of these were associated with carriage. Factors affecting the prevalence of iNTS may differ from those associated with NTS carriage. The apparent geographical differences may be explained by seasonality in occurrence of iNTS disease, since the sampling in the sites was done at different calendar times and seasons. Given the cross-sectional nature of the study, we could not assess the seasonal changes in NTS carriage. We could also not estimate how many of the cases of NTS carriage were asymptomatic or preceded or followed an invasive episode, though 18% of the participants (51% of whom were under 5y) had a febrile illness and 8% (67% of whom were under 5y) had a diarrhea episode in the 2 weeks prior to enrolment in the study. None of these risk factors when analyzed was associated with carriage.

Age-specific carriage prevalence observed in this study were similar to observations from Guinea-Bissau [25]; notably high carriage prevalence among adults and older children and low carriage prevalence among children aged <5 years. This could be explained by age-related differences in the acquisition of infection and persistence of infection. As NTS is a fecal-oral pathogen, neonates are exposed to it during vaginal delivery [43] but, subsequently, due to limited mobility and breastfeeding, their interactions with environmental sources of NTS in infancy are limited. On the other hand, older children and adults interact with a wider range of sources of NTS through the food supply such as animal meat and products such as dairy and eggs, and both raw and cooked vegetables, which are likely sources and may lead to colonization. Previous studies report a median duration of carriage of 7 weeks in children aged <5 years and 3–4 weeks in older children and adults [44]. Given that carriage prevalence rises with age in children, this implies that acquisition rates rise even more steeply with age [45].

This study was limited by the low sensitivity of stool culture for recovery of NTS. Also, given the cross-sectional nature of the sampling and the intermittent shedding of NTS among carriers, the estimates of prevalence in this study are likely to be underestimates of the true prevalence. Due to the low yield, we could not assess the relative prevalence of S. Typhimurium (1 isolate) to S. Enteritidis (5 isolates) recovered in this study. The current ratio does not reflect the known distribution of the two serotypes in Kenya (1:1). Use of multiple samples per time point [26] and use of direct-stool PCR with enrichment [46] may have improved the yield of Salmonella. We also lacked full serotype and genotype data of the isolates, and therefore could not comment on the invasiveness of all the isolates identified nor characterize the sequence types of interest such as S. Typhimurium ST313 and the different clades of S. Enteritidis.

Despite these limitations, this study provides comparative estimates of the prevalence of NTS carriage across different geographical locations in Kenya. Kilifi, the area with the lowest incidence of iNTS disease [17,18], had the highest prevalence of carriage (13%), while Siaya and Nairobi, which are areas of high and moderate disease incidence [19], had low carriage prevalence (0.9%, 0.2%). The observation suggests that diverse carriage strains, with lower invasive potential, could have a protective advantage if they induce a degree of cross-reactive immunity among the carriers. Further characterization of the isolates recovered, including sequencing, could enable identification of common antibody targets that might support this hypothesis.

Supporting information

S1 Table. Risk factors associated with fecal carriage of NTS in Kilifi.

(DOCX)

Acknowledgments

We thank the field, laboratory and clerical staff of the NTS Project in Kilifi, Nairobi and Siaya, and the study participants.

Data Availability

All data relevant to the study are included in the article or uploaded as supplementary information.

Funding Statement

E.M.M is supported through the DELTAS Africa Initiative [DEL-15-003]. The DELTAS Africa Initiative is an independent funding scheme of the African Academy of Sciences (AAS)'s Alliance for Accelerating Excellence in Science in Africa (AESA) and supported by the New Partnership for Africa's Development Planning and Coordinating Agency (NEPAD Agency) with funding from the Wellcome Trust and the UK government. J.A.G.S is supported by a Wellcome Trust Senior Fellowship (214320). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. The findings and conclusions in this report are those of the authors and do not necessarily represent the official position of the U.S. Centers for Disease Control and Prevention. This article was published with the approval of the KEMRI Director.

References

  • 1.Hohmann EL. Nontyphoidal salmonellosis. Clin Infect Dis. 2001;32(2):263–9. doi: 10.1086/318457 [DOI] [PubMed] [Google Scholar]
  • 2.Aiken AM, Lane C, Adak GK. Risk of Salmonella infection with exposure to reptiles in England, 2004–2007. Euro Surveill. 2010;15(22):19581. [PubMed] [Google Scholar]
  • 3.Hoelzer K, Moreno Switt AI, Wiedmann M. Animal contact as a source of human non-typhoidal salmonellosis. Vet Res. 2011;42(1):34. doi: 10.1186/1297-9716-42-34 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 4.Majowicz SE, Musto J, Scallan E, et al. The global burden of nontyphoidal Salmonella gastroenteritis. Clin Infect Dis. 2010;50(6):882–9. doi: 10.1086/650733 [DOI] [PubMed] [Google Scholar]
  • 5.Ao TT, Feasey NA, Gordon MA, et al. Global burden of invasive nontyphoidal Salmonella disease, 2010(1). Emerg Infect Dis. 2015;21(6):941–9. doi: 10.3201/eid2106.140999 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 6.Collaborators GBD. The global burden of non-typhoidal salmonella invasive disease: a systematic analysis for the Global Burden of Disease Study 2017. Lancet Infect Dis. 2019;19(12):1312–24. doi: 10.1016/S1473-3099(19)30418-9 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 7.Feasey NA, Dougan G, Kingsley RA, Heyderman RS, Gordon MA. Invasive non-typhoidal salmonella disease: an emerging and neglected tropical disease in Africa. Lancet. 2012;379(9835):2489–99. doi: 10.1016/S0140-6736(11)61752-2 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 8.Kariuki S, Revathi G, Kariuki N, et al. Invasive multidrug-resistant non-typhoidal Salmonella infections in Africa: zoonotic or anthroponotic transmission? J Med Microbiol. 2006;55(Pt 5):585–91. doi: 10.1099/jmm.0.46375-0 [DOI] [PubMed] [Google Scholar]
  • 9.Dione MM, Ikumapayi UN, Saha D, et al. Clonal differences between Non-Typhoidal Salmonella (NTS) recovered from children and animals living in close contact in the Gambia. PLoS Negl Trop Dis. 2011;5(5):e1148. doi: 10.1371/journal.pntd.0001148 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 10.Post AS, Diallo SN, Guiraud I, et al. Supporting evidence for a human reservoir of invasive non-Typhoidal Salmonella from household samples in Burkina Faso. PLOS Neglected Tropical Diseases. 2019;13(10):e0007782. doi: 10.1371/journal.pntd.0007782 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 11.Kingsley RA, Msefula CL, Thomson NR, et al. Epidemic multiple drug resistant Salmonella Typhimurium causing invasive disease in sub-Saharan Africa have a distinct genotype. Genome Res. 2009;19(12):2279–87. doi: 10.1101/gr.091017.109 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 12.Feasey NA, Hadfield J, Keddy KH, et al. Distinct Salmonella Enteritidis lineages associated with enterocolitis in high-income settings and invasive disease in low-income settings. Nat Genet. 2016;48(10):1211–7. doi: 10.1038/ng.3644 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 13.Statistics Kenya National Bureau of Statistics. Kenya Population and Housing Census. 2019;II. [Google Scholar]
  • 14.Feikin DR, Olack B, Bigogo GM, et al. The burden of common infectious disease syndromes at the clinic and household level from population-based surveillance in rural and urban Kenya. PLoS One. 2011;6(1):e16085. doi: 10.1371/journal.pone.0016085 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 15.Kenya National Bureau of Statistics, International I. Kenya Malaria Indicator Survey 2015. 2016. [Google Scholar]
  • 16.Ministry of Health, Ministry of Planning. Kenya AIDS Indicator Survey 2012. 2014. [Google Scholar]
  • 17.Muthumbi E, Morpeth SC, Ooko M, et al. Invasive Salmonellosis in Kilifi, Kenya. Clin Infect Dis. 2015;61 Suppl 4(Suppl 4):S290–301. doi: 10.1093/cid/civ737 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 18.Berkley JA, Lowe BS, Mwangi I, et al. Bacteremia among children admitted to a rural hospital in Kenya. N Engl J Med. 2005;352(1):39–47. doi: 10.1056/NEJMoa040275 [DOI] [PubMed] [Google Scholar]
  • 19.Verani JR, Toroitich S, Auko J, et al. Burden of Invasive Nontyphoidal Salmonella Disease in a Rural and Urban Site in Kenya, 2009–2014. Clin Infect Dis. 2015;61 Suppl 4(Suppl 4):S302–9. doi: 10.1093/cid/civ728 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 20.Scott JA, Bauni E, Moisi JC, et al. Profile: The Kilifi Health and Demographic Surveillance System (KHDSS). Int J Epidemiol. 2012;41(3):650–7. doi: 10.1093/ije/dys062 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 21.Odhiambo FO, Laserson KF, Sewe M, et al. Profile: the KEMRI/CDC Health and Demographic Surveillance System—Western Kenya. Int J Epidemiol. 2012;41(4):977–87. doi: 10.1093/ije/dys108 [DOI] [PubMed] [Google Scholar]
  • 22.Mbae C, Mwangi M, Gitau N, et al. Factors associated with occurrence of salmonellosis among children living in Mukuru slum, an urban informal settlement in Kenya. BMC Infectious Diseases. 2020;20(1):422. doi: 10.1186/s12879-020-05134-z [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 23.CLSI Performance Standards for Antimicrobial Susceptibility Testing. 28th Edition. CLSI Supplement M100. 28 ed. Wayne PA: Clinical and Laboratory Stanards Institute; 2018. [Google Scholar]
  • 24.World Health Organization. Child Growth Standards: World HEalth Organization; 2006. [Available from: https://www.who.int/tools/child-growth-standards/standards. [Google Scholar]
  • 25.Im J, Nichols C, Bjerregaard-Andersen M, et al. Prevalence of Salmonella Excretion in Stool: A Community Survey in 2 Sites, Guinea-Bissau and Senegal. Clin Infect Dis. 2016;62 Suppl 1(Suppl 1):S50–5. doi: 10.1093/cid/civ789 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 26.Mbuyi-Kalonji L, Barbé B, Nkoji G, et al. Non-typhoidal Salmonella intestinal carriage in a Schistosoma mansoni endemic community in a rural area of the Democratic Republic of Congo. PLoS Negl Trop Dis. 2020;14(2):e0007875. doi: 10.1371/journal.pntd.0007875 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 27.Kasumba IN, Pulford CV, Perez-Sepulveda BM, et al. Characteristics of Salmonella Recovered From Stools of Children Enrolled in the Global Enteric Multicenter Study. Clin Infect Dis. 2021;73(4):631–41. doi: 10.1093/cid/ciab051 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 28.Reddy EA, Shaw AV, Crump JA. Community-acquired bloodstream infections in Africa: a systematic review and meta-analysis. Lancet Infect Dis. 2010;10(6):417–32. doi: 10.1016/S1473-3099(10)70072-4 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 29.Hsieh YC, Lin PY, Chiu CH, Huang YC, Chang KY, Liao CH, et al. National survey of invasive pneumococcal diseases in Taiwan under partial PCV7 vaccination in 2007: emergence of serotype 19A with high invasive potential. Vaccine. 2009;27(40):5513–8. doi: 10.1016/j.vaccine.2009.06.091 [DOI] [PubMed] [Google Scholar]
  • 30.Tabu C, Breiman RF, Ochieng B, et al. Differing burden and epidemiology of non-Typhi Salmonella bacteremia in rural and urban Kenya, 2006–2009. PLoS One. 2012;7(2):e31237. doi: 10.1371/journal.pone.0031237 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 31.Gilchrist JJ, MacLennan CA, Hill AV. Genetic susceptibility to invasive Salmonella disease. Nat Rev Immunol. 2015;15(7):452–63. doi: 10.1038/nri3858 [DOI] [PubMed] [Google Scholar]
  • 32.Blaser MJ, Newman LS. A review of human salmonellosis: I. Infective dose. Rev Infect Dis. 1982;4(6):1096–106. doi: 10.1093/clinids/4.6.1096 [DOI] [PubMed] [Google Scholar]
  • 33.Andino A, Hanning I. Salmonella enterica: survival, colonization, and virulence differences among serovars. ScientificWorldJournal. 2015;2015:520179. doi: 10.1155/2015/520179 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 34.Cheng RA, Eade CR, Wiedmann M. Embracing Diversity: Differences in Virulence Mechanisms, Disease Severity, and Host Adaptations Contribute to the Success of Nontyphoidal Salmonella as a Foodborne Pathogen. Front Microbiol. 2019;10:1368. doi: 10.3389/fmicb.2019.01368 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 35.Jones TF, Ingram LA, Cieslak PR, et al. Salmonellosis outcomes differ substantially by serotype. J Infect Dis. 2008;198(1):109–14. doi: 10.1086/588823 [DOI] [PubMed] [Google Scholar]
  • 36.Ramachandran G, Perkins DJ, Schmidlein PJ, Tulapurkar ME, Tennant SM. Invasive Salmonella Typhimurium ST313 with naturally attenuated flagellin elicits reduced inflammation and replicates within macrophages. PLoS Negl Trop Dis. 2015;9(1):e3394. doi: 10.1371/journal.pntd.0003394 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 37.Achtman M, Wain J, Weill F-X, et al. Multilocus Sequence Typing as a Replacement for Serotyping in Salmonella enterica. PLOS Pathogens. 2012;8(6):e1002776. doi: 10.1371/journal.ppat.1002776 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 38.Kariuki S, Mbae C, Van Puyvelde S, et al. High relatedness of invasive multi-drug resistant non-typhoidal Salmonella genotypes among patients and asymptomatic carriers in endemic informal settlements in Kenya. PLoS Negl Trop Dis. 2020;14(8):e0008440. doi: 10.1371/journal.pntd.0008440 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 39.Parisi A, Le Thi Phuong T, Mather AE, et al. Differential antimicrobial susceptibility profiles between symptomatic and asymptomatic non-typhoidal Salmonella infections in Vietnamese children. Epidemiol Infect. 2020;148:e144. doi: 10.1017/S0950268820001168 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 40.Parisi A, Phuong TLT, Mather AE, et al. The role of animals as a source of antimicrobial resistant nontyphoidal Salmonella causing invasive and non-invasive human disease in Vietnam. Infect Genet Evol. 2020;85:104534. doi: 10.1016/j.meegid.2020.104534 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 41.Le Thi Phuong T, Rattanavong S, Vongsouvath M, et al. Non-typhoidal Salmonella serovars associated with invasive and non-invasive disease in the Lao People’s Democratic Republic. Trans R Soc Trop Med Hyg. 2017;111(9):418–24. doi: 10.1093/trstmh/trx076 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 42.Biggs HM, Lester R, Nadjm B, et al. Invasive Salmonella infections in areas of high and low malaria transmission intensity in Tanzania. Clin Infect Dis. 2014;58(5):638–47. doi: 10.1093/cid/cit798 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 43.Talbert AW, Mwaniki M, Mwarumba S, Newton CR, Berkley JA. Invasive bacterial infections in neonates and young infants born outside hospital admitted to a rural hospital in Kenya. Pediatr Infect Dis J. 2010;29(10):945–9. doi: 10.1097/INF.0b013e3181dfca8c [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 44.Buchwald DS, Blaser MJ. A review of human salmonellosis: II. Duration of excretion following infection with nontyphi Salmonella. Rev Infect Dis. 1984;6(3):345–56. doi: 10.1093/clinids/6.3.345 [DOI] [PubMed] [Google Scholar]
  • 45.Freeman J, Hutchison GB. Prevalence, incidence and duration. Am J Epidemiol. 1980;112(5):707–23. doi: 10.1093/oxfordjournals.aje.a113043 [DOI] [PubMed] [Google Scholar]
  • 46.Lin LH, Tsai CY, Hung MH, Fang YT, Ling QD. Rectal swab sampling followed by an enrichment culture-based real-time PCR assay to detect Salmonella enterocolitis in children. Clin Microbiol Infect. 2011;17(9):1421–5. doi: 10.1111/j.1469-0691.2010.03450.x [DOI] [PubMed] [Google Scholar]

Associated Data

This section collects any data citations, data availability statements, or supplementary materials included in this article.

Supplementary Materials

S1 Table. Risk factors associated with fecal carriage of NTS in Kilifi.

(DOCX)

Data Availability Statement

All data relevant to the study are included in the article or uploaded as supplementary information.


Articles from PLOS Neglected Tropical Diseases are provided here courtesy of PLOS

RESOURCES